Press Releases March 29, 2026 08:00 PM

Synergy CHC Corp. Announces Date Change of Fourth Quarter and Full Year 2025 Earnings and Conference Call

Synergy CHC Corp. schedules earnings release and conference call for Q4 and full year 2025 results

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
SNYR

Synergy CHC Corp., a consumer health and wellness company, announced its updated date for releasing fourth quarter and full year 2025 financial results on April 1, 2026, prior to market open. The company will host a live conference call with executives to discuss the results, accessible via webcast and phone. Synergy's leading brands include FOCUSfactor and Flat Tummy, with established distribution across major retailers and ongoing market expansion.

Synergy CHC Corp. Announces Date Change of Fourth Quarter and Full Year 2025 Earnings and Conference Call
SNYR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Earnings release for Q4 and full year 2025 scheduled for April 1, 2026 before market open.
  • Conference call with CEO and CFO to discuss financial results will be held on the release day.
  • Synergy’s flagship brands FOCUSfactor and Flat Tummy have broad retail distribution and are expanding markets internationally.

WESTBROOK, Maine, March 30, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced an updated date for the release of its fourth quarter and full year financial results ended December 31, 2025. The Company will now report its financial results on Wednesday, April 1, 2026, before the open of market trading.

In conjunction with reporting fourth quarter and full year 2025 results, Synergy will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT with the Company’s Chief Executive Officer, Jack Ross, and the Company’s Chief Financial Officer, Jaime Fickett. A live webcast of the call will be available on the Investor Relations section of Synergy’s website. To access the call by phone, please register here and you will be provided with dial-in details. To avoid delays, we encourage participants to dial into the conference call 15 minutes ahead of the scheduled start time. A replay of the webcast will also be available for a limited time on the Company’s website.

About Synergy CHC Corp.

Synergy CHC Corp. develops and markets consumer health and wellness products, led by its flagship brands FOCUSfactor® and Flat Tummy®. FOCUSfactor®, a clinically studied brain health supplement and functional beverage line with a 25-year legacy, enjoys established distribution in the U.S., Canada, Mexico and the U.K. through major retailers including Costco, Walmart, Amazon, BJ's, and Walgreens, among others. The brand continues to accelerate growth, penetrating new markets both domestically and internationally, with recent retail wins across mass, grocery, pharmacy, convenience, and wholesale channels poised to drive meaningful gains. Flat Tummy® complements Synergy's portfolio as a lifestyle brand focused on women's wellness and weight management.

Investor Relations

Gateway Group
Cody Slach, Greg Robles
949.574.3860
SNYR@gateway-grp.com


Risks

  • Potential market volatility around the earnings release due to financial performance uncertainties.
  • Risks associated with international market expansion and new retail channel penetration.
  • Dependence on continued consumer demand in the competitive health and wellness sector.

More from Press Releases

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems Jun 6, 2026 All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration Jun 6, 2026 Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress Jun 6, 2026 InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public Offering Jun 5, 2026 Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 5, 2026